Del-Immune V® Study Presented at EUPROBIO 2008

BOULDER, Colo.—An abstract titled, “Immune regulatory cytokines Del-Immune V® induction and its impact on cytotoxicity of natural killer cells” will be presented to physicians, researchers and educators on Thursday, Oct. 16 at the EUPROBIO 2008 Conference.
Attendees will learn about the latest advancements in this field of research. The abstract is based on a recent study focusing on Del-Immune V, a new immunomodulator containing DNA and peptoglycan fragments of lactobacillus rhamnosus V. The study, which confirms this formulation enhances immune function, was conducted in the Ukraine by several of Europe's foremost research scientists.
Among other findings, the study demonstrated that daily administration of Del-Immune V within five days raised a level of circulating interferon up to 4.2+/-0.5 log2 u/ml (P<0.05) against 2.0+/-0.3 log2 u/ml of the controls.
Interferons are the switches that help cells resist viral infection and provide the initial, crucial immune response to immune challenges. The results of this latest research demonstrate the immune modulator activity of Del-Immune V and the potential value the dietary supplement may have in clinical situations.
Del-Immune V is a dietary supplement containing a natural culture that starts with healthy bacteria originally found in unpasteurized milk. Unique technological processing of the Del-Immune V formulation creates a natural immunostimulant. The study described above and other research indicates it could be beneficial in assisting the body’s natural role of protecting the body from germs, viruses and other bodily invaders.

www.DelImmune.com